Source

TLV (Swedish HTA)

Regulation Category Type · Breadth Date

Two drainable one-piece stoma pouches for infants approved for inclusion in Swedish pharmaceutical benefits from 14 September 2026.

TLV (Swedish HTA) · Sweden

Market Access & ReimbursementOther Regulated Products Reimbursement

Approval & opinion Product class ⏲ Sep 14, 2026 Aug 31, 2026

TLV approves Ally Powder stoma powder for inclusion in Sweden's high-cost protection scheme from 9 September 2026.

TLV (Swedish HTA) · Sweden

Market Access & Reimbursement Reimbursement

Approval & opinion Product class ⏲ Sep 09, 2026 Aug 26, 2026

Lazcluze (lazertinib) for advanced non-small-cell lung cancer is included in Swedish high-cost protection from 1 September 2026.

TLV (Swedish HTA) · Sweden

PharmaceuticalsMarket Access & Reimbursement Reimbursement Pharmaceuticals

Approval & opinion Product class Aug 25, 2026

Showing 3 of 3 tracked updates Health-tech only